Medpace (MEDP) earnings, Oct 21, 2026: EPS +25%, stock +6.4%
In brief
Medpace reported on Oct 21, 2026. Earnings per share changed +25% year over year, 9.1% above the estimate; revenue +9%. The stock opened with a −1.2% gap and closed the day +6.4% (Oct 21, 2026). The stock is now 8.5% below its 52-week high, +6.0% over 12 months. Next report: Feb 15, 2027.
EPS vs estimate+9.1%
EPS, YoY+25%
Revenue, YoY+9%
Gap · day−1.2% · +6.4%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 22, 2026 | +22.5% | +14.7% |
| Oct 21, 2026 | −1.2% | +6.4% |
Next-quarter estimates, ratings and the MEDP chart are in the terminal.
Open the terminalFAQ
When is Medpace's next earnings report?
Feb 15, 2027. The date comes from daily data and is corrected if the company moves it.
How did Medpace stock react to the report?
Opening gap −1.2%, day's result +6.4%.
Did Medpace's earnings grow?
Earnings per share rose 25% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.